The store will not work correctly when cookies are disabled.
4-(4-(3,6-dichloro-9H-carbazol-9-yl)butyl)morpholine
ID: ALA5282994
Max Phase: Preclinical
Molecular Formula: C20H22Cl2N2O
Molecular Weight: 377.32
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1ccc2c(c1)c1cc(Cl)ccc1n2CCCCN1CCOCC1
Standard InChI: InChI=1S/C20H22Cl2N2O/c21-15-3-5-19-17(13-15)18-14-16(22)4-6-20(18)24(19)8-2-1-7-23-9-11-25-12-10-23/h3-6,13-14H,1-2,7-12H2
Standard InChI Key: NXEVXQUJSINAEF-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
3.1160 -2.1525 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.5444 -1.8225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5444 -0.9975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8300 -0.5850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1155 -0.9975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3312 -0.7426 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1536 -1.4100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9735 -1.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3090 -2.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8240 -2.9169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0037 -2.8307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3312 -2.0774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1155 -1.8225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8300 -2.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0925 -3.5199 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.0752 0.0406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7324 0.2112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9889 0.9958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7966 1.1664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0526 1.9509 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8600 2.1215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1160 2.9060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5646 3.5199 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7572 3.3494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5012 2.5649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
12 13 1 0
13 5 2 0
13 14 1 0
14 2 2 0
10 15 1 0
6 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
21 20 1 0
22 21 1 0
23 22 1 0
24 23 1 0
25 24 1 0
20 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 377.32 | Molecular Weight (Monoisotopic): 376.1109 | AlogP: 5.21 | #Rotatable Bonds: 5 |
Polar Surface Area: 17.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 7.78 | CX LogP: 4.90 | CX LogD: 4.37 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.57 | Np Likeness Score: -1.25 |
References
1. Clausen JD, Kjellerup L, Cohrt KO, Hansen JB, Dalby-Brown W, Winther AL.. (2017) Elucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivatives., 27 (19): [PMID:28893470] [10.1016/j.bmcl.2017.08.067] |